This blog post explains the rationale for SugoSure's design and explains how this innovative and transformational digital health system addresses overlooked areas in diabetes care and delivers a more complete approach built around best practice protocols.

Summary findings from the SugoSure Beta Test carried out from November 2019 with a pre-commercial release version of SugoSure. Patients with a starting HbA1c of > 7.0% showed an average reduction of 0.9% in HbA1c and 1.0 mmol/L fasting blood glucose after 3 months' SugoSure use.

What is comprehensive diabetes management and why is it important? This blog post explains the five essential functions needed for complete management of diabetes and looks at the approaches taken by different digital health solutions.